Carolina Herrera presents the new fragrance, 212 VIP, inspired by New York’s most creative people, the young talents who are writing the future history of the city, people who want to have a good time.

212 VIP is a fun, festive and floral fragrance that combines style with attitude and hits three essential notes:
FUN: accords of heady rum and exotic passion fruit. An explosive cocktail to be enjoyed at anytime!
SOCIALITE: an essential feature of the new 212 VIP generation, created from notes of abundant musk and distinguished gardenia. An exceptional aura.
STYLISH: ingredients that bring a unique and extraordinary charm, among them delicious and ultra-feminine vanilla and sensual tonka bean. A touch of originality and sophistication.

The bottle, an object of pure desire, is a dazzling gold giving the product a magical luminosity. With its attractive, feminine and curvaceous lines, it is beautifully and lovingly conceived, right through to its magnetic lid.

212 VIP EDP 30ml – 31
212 VIP EDP 50ml – 43.50
212 VIP EDP 80ml – 59
212 VIP Body lotion (200 ml) – 25.50
212 VIP Bath & Shower gel (200 ml) – 24.75

On counter – 22nd September 2010

Source:cosmeticnewsportal.com

Scholl has taken a measure of the nations feet and we have found a lot of pain and suffering, says SSL Marketing Director Mark Critchley. As the leading footcare expert, Scholl believes people should better appreciate their hard-working feet, which keep this country going.

Victoria Beckham well known for her soaring stilettos – has the worst feet in the nation (71%), followed by Sarah Brown (11%). 67% thought Posh should have urgent surgery to deal with her bunions.

70% polled would avoid wearing high heels if they thought they would suffer from bunions. And if they did have a bunion operation, 76% fear the general disruption to their lives including not being able to drive to work, weight gain fears and not being able to wear their beloved high heels.

Despite the possible health hazards, women feel sexier wearing high heels (81%) and 7% of women have loved their shoes so much – that they have even worn them to bed!

Not everyone is hooked on heels; almost 60% of women would wear flats to make their shorter partner happy and one in ten men admit to wearing lifts in their shoes.

The poll reveals the vast majority of men are not grossed out by other peoples feet (73%) perhaps because 46% of them have had athletes foot. 52% of men, however, say they would be most put off by hairy toes; while women cited athletes foot (45%) as their biggest turnoff.

Contrary to their other halves, the majority of women (51%) are indeed grossed out by unattractive feet.

More Foot Stats
When faced with a choice between stocking the cupboard or buying another pair of shoes, 33% of women say they would rather starve – while only 12% of men opted to give up their rations
Half the nation has admitted to buying a new pair of ill-fitting shoes – knowing theyd never be comfortable enough to wear
In fact, our shoes can be so painful that nearly half of us (46%) carry an extra pair of more comfortable shoes around with us
Despite any possible health hazards, the nation only wants to buy more shoes! More than 75% want more money at the end of the month to spend on footwear
If you do open a womans wardrobe, youre liable to be hit by an avalanche of shoes. Nearly a third (31%) confesses to owning from 11-20 pairs!
And theyre not always comfortable, which perhaps accounts for why so many pairs are left at the office. 27% of Brits have from one to five pairs of shoes lurking underneath their desks at work
Nearly half the nation (49%) is not bothered by shoe labels. Of those that are, the most coveted shoe labels for women ages 16 to 40 are Jimmy Choo (30%), Christian Louboutin (28%) and Manolo Blahnik (15 %)
And the most preferred heel height? For more than half of women (52%), its from one to two inches high, while an intrepid 2% totter about on four inches or higher
79% would not like their feet handled by a celebrity; of the 21% who would, its Cheryl Cole for the men and hands down George Clooney for the women
14% said they would like to massage a celebritys feet. And again – its Cheryl Cole for the men and George Clooney for the women
Of all the feet in the nation, respondents singled out nurses as having Britains Hardest Working Feet (54%)

Source:cosmeticnewsportal.com

Angela explains: “The best way is to start with one or two pumps of a specialist serum – massage it into your skin and then follow with a couple of drops of luxury face oil. This will absorb quickly into your skin – so you can then apply your make-up”.

There are four such products in the Angela Langford range for customers to try, depending on their skin type and condition. Two specialist natural serums that contain high levels of water loving active raw materials such as water soluble vitamins and plant derived Hyaluronic Acid; as well as two luxurious natural face oils, containing a blend of cold pressed natural and organic plant oils, vitamins and other oil loving active raw materials like Q10.

There’s a combination of natural serum and face oils to suit everyone, but Angela is well aware that many people are frightened of putting oil on their face.

“People associated oil with oily skin; but this isn’t the case. Using a face oil, even if you have oily skin, can actually help improve the condition of your skin and some oils can even balance an oily complexion – helping to turn it back into “normal” skin. The important thing is knowing which oils are suitable for which skin type.”

Source:cosmeticnewsportal.com

These are perfumes that inspire confidence and help women create an impact when they enter a room, leaving a trace of scent in their wake and a memory on the minds of those they meet.

Marc Jacobs Lola
A modern, free spirit with an irresistible attitude. Relaxed, cool and confident. Sexy with a flirtatious wink. This feminine bottle is a must have for the Christmas treats list and a perfect stocking filler for her. The EDP 50ml is available at The Perfume Shop at 44.50.

Versace Versus
Combining contrasting elements in a game of opposites, this is the ideal fragrance for a woman who loves to dare. Romantic to aggressive; punk to melodious; tough to feminine, it is dedicated to a cutting edge, confident, seductive woman. The EDT 50ml is available at The Perfume Shop at 39.99.

Dolce & Gabbana Rose The One For Women
A scent that reveals, petal by petal a womans intimate and precious femininity. Scarlett Johansson is the face of this fragrance and bring her delicate feminity and sensual mood to this soft perfume. The EDP 30ml is available at The Perfume Shop at 33.50.

The Perfume Shop also recommends the following fragrances for pure adoration this season:
1. Angel Gift Set
2. Ghost Sweetheart
3. Lacoste Love Of Pink
4. Prada LEau Ambree
5. Dior JAdore

Source:cosmeticnewsportal.com

Greenton (London) revolutionised the sector by introducing the world’s most advanced compact IPL system. For the first time, beauty professionals and their clients could benefit from the highest-grade IPL and advanced treatments in a portable concept that costs a fraction of other systems on the market. Without compromising on the quality of treatments, and with proven results, Ecolite quickly established a strong presence in Europe, Japan, the USA and Middle-East to become the brand of choice for therapists in over 34 countries.

The new Ecolite V9 system boasts even more advanced features and increased treatment options supported with improved computer software. The newly designed machine also brings a contemporary new look to Ecolite that reflects its status as high-tech, technology driven equipment.

In addition to delivering all the treatment benefits of the Ecolite V8, Ecolite now features a medically approved IPL skin resurfacing protocol. Director Virgil Bhaloo explains; “This procedure gently, yet effectively, removes the top layers of dead, scarred and blemished skin to reveal newer, fresher layers beneath. It literally transforms the complexion and leaves it smoother and younger looking with a significant reduction of lines, wrinkles, scars, blemishes and other marks on the skin.”

Ecolite has also launched disposable heads designed for the removal of fine hair. “This disposable cover for the lamp head literally vaporises fine hair,” says, Virgil Bhaloo. “Traditionally, all IPL systems have struggled to generate sufficient heat to effectively remove very fine hair. This development makes this possible with a very simple and hygienic concept that simply clips on. Now therapists can achieve a clean, smooth finish and remove even the finest hair!”

Recognised by beauty professionals and consumers to effectively overcome many skin issues and transform the appearance of skin, the Ecolite V9 can literally revolutionise your beauty business, as well as boosting the confidence and self-esteem of clients. With these latest developments from Ecolite, salons, spas and skin clinics can introduce highly effective IPL services and profit from this extremely popular technology without the huge investment required by other manufacturers.

At just 9,950.00 Ecolite delivers uncompromising results, as well as providing the following benefits to your business.

* FREE ONGOING SERVICING WITH NO CONTRACTS
* A LAMP LIFE OF 70,000 SHOTS AT JUST 0.0035p PER SHOT
* A SYSTEM THAT IS UP TO 250 TIMES LESS EXPENSIVE THAN EQUIVALENT IPL SYSTEMS!
* LOWEST REFURBISHMENT COST IN THE INDUSTRY – ECOLITE IS 50% LESS EXPENSIVE TO RUN
* THE CONFIDENCE OF OVER 2000 BEAUTY BUSINESS IN 34 COUNTRIES WHO TRUST IN ECOLITE

In addition to these new developments, Ecolite offers the following existing benefits.

Permanent hair reduction
Suffer the embarrassment of unwanted or excessive facial hair no longer. IPL is proven to deliver a significant reduction of unsightly hair, which can dramatically improve confidence and self esteem!

Skin Tone Improvement
Ecolite evens out skin tone by removing blemishes, marks and other skin imperfections.

Acne and Scarring
Acne, acne scarring and other scars on the skin can be effectively treated, including conditions such as Roseacea and sun damage.

Skin Rejuvenation
Ecolite visibly rejuvenates skin and produces noticeable anti-aging benefits. Dull upper layers of the skin are removed to uncover a fresher, younger looking complexion.

Source:cosmeticnewsportal.com

Easy to apply and even easier to take on the go, Emani Pressed Mineral Foundation provides amazing coverage. The gorgeous compact comes complete with a unique anti-bacterial sponge which can be cleaned as often as necessary.

Infused with organic rosemary and grape seed extract, this mineral-based pressed foundation helps to balance your skins natural moisture. Grape seed oil is high in linoleic acid which is renowned for its beneficial properties on the skin. Linoleic acid acts as an anti-inflammatory, is acne reductive and helps to retain skins natural moisture. Organic Rosemary acts as an anti-oxidant and is a skin conditioning agent.

Available in 15 colour options to suit all skin tones.
23.95

Each Emani Mineral product is vegan, and free of talc, gluten or parabens.

Source:cosmeticnewsportal.com

The Medicines and Healthcare products Regulatory Agency (MHRA) has received encouraging results of UK testing on the silicone gel breast implants manufactured by the French company Poly Implant Prosthese (PIP).

The tests found no evidence of genotoxicity (potential for cancer) or chemical toxicity of the filler material in the implants.

The tests are not as extensive as those being carried out in France, but they have provided initial information as to whether there is a safety issue with the filler material.

MHRA Director of Devices Clinical, Dr Susanne Ludgate said, “It’s reassuring that our test results have shown no evidence of any associated risks with the filler material.

“We are however waiting for the results of the French tests which are more extensive and include mechanical testing of the implant shell because there maybe a suggestion of an increased rupture rate compared with other breast implants. We will update clinicians and women once these test results are available and provide further advice on patient management as necessary.

“If women have any concerns, they should speak to their implanting surgeon.

“Implanting surgeons should report any clinical and radiological problems associated with these implants to the MHRA Adverse Incident Centre.

“Further advice and information can be obtained from the Association of Breast Surgery and the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS).”

Notes

1. As these products have been widely used in the UK, the MHRA was keen to identify as early as possible any potential toxicity associated with the implant filler. It therefore commissioned independent UK testing.

2. The previous press release about this issue can be seen on the MHRA website: Advice issued to breast implant surgeons

4. In general, a medical device cannot be marketed in the UK without carrying a CE Mark of Conformity. A CE mark is applied by the manufacturer to denote that the device meets the relevant regulatory requirements and performs as intended. For all but the very lowest risk devices, such as unmedicated bandages, an EC Certificate of Conformity must be obtained from an independent certification organisation, called a Notified Body, before the CE marking can be affixed. The MHRA is responsible for designating UK Notified Bodies and regularly audits them to ensure that they continue to perform to the required standards.

Source:

MHRA

The European Society of Cardiology (ESC) announces the release of new Clinical Practice Guidelines covering the management of Grown-up Congenital Heart Disease (GUCH). More than two million adults in Europe are assumed to be affected by the condition, and the numbers are growing as a consequence of sharply increased survival rates due to advances in paediatric cardiology and heart surgery. The new guidelines enhance and update the recommendations contained in an earlier version issued in 2003, and will be presented at the ESC Congress in Stockholm on 29 August during the Clinical Practice Guidelines session in lecture room Stockholm, Zone K, starting at 0910hrs.

GUCH is a condition that requires a complex and demanding management regime. The Chair of the Task Force responsible for drafting and issuing the guidelines is Professor Helmut Baumgartner of University Hospital, Muenster in Germany. He has a great deal of experience in the treatment and care of patients with GUCH, and is a former Chair of the ESC Working Group that is focused on that condition. Professor Baumgartner says, “The document describes the many ongoing problems encountered in adults with congenital heart disease. These patients frequently face great difficulties as adults in the management of their condition, and what we expect to achieve with these guidelines is a series of detailed recommendations that will help improve their quality of life.”

The new guidelines build on the knowledge gained when compiling the 2003 version. Since randomised controlled trials are the exception in this field, its recommendations are mainly based on expert consensus, observational studies and registries. It expands previously tabulated content into a full and detailed description of the 18 most common sub-sets of the condition, detailing the most effective management for each, including:

– The use of echocardiography, computer topography (CT), magnetic resonance (MR), catheterisation and other diagnostic techniques

– Decision-making on the timing of surgical or catheter intervention and re-intervention

– Ongoing monitoring and medical treatments

Successful management of GUCH requires a multi-disciplinary approach. As well as drawing in experts in the condition itself and in general cardiology, the Task Force was represented by the Association for European Paediatric Cardiology (AEPC) and the following ESC entities:

– Associations: European Association for Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and the European Association of Echocardiography (EAE)

– Councils: Cardiology Practice, Council on Primary Care, Cardiovascular Imaging, and Cardiovascular Nursing and Allied Professions

– Working Groups: Grown-up Congenital Heart Disease, Pulmonary Circulation and Right Ventricle Function, Valvular Heart Disease, Cardiovascular Surgery, Thrombosis, and Acute Cardiac Care

Professor Baumgartner is pleased to have led the Task Force that developed the new guidelines. “These patients are very demanding, and there is no doubt that there are a wide range of special needs in their care and treatment,” he says. “We do hope that this document can help to improve the quality of GUCH care.”

Practitioners that will be using the new guidelines, as well as journalists, are offered the opportunity to have an open discussion and Q&A with Professor Baumgartner and two members of the Task Force. A ‘Meet the Guidelines Task Force’ session takes place on Monday 30 August in lecture room Moscow, Zone A starting at 1245.

Sources: European Society of Cardiology (ESC), AlphaGalileo Foundation.

The European Society of Cardiology (ESC) announces the release of new Clinical Practice Guidelines covering Myocardial Revascularisation. These guidelines were developed following pioneering and extensive co-operation between the ESC and the European Association of Cardio-Thoracic Surgeons (EACTS). Myocardial Revascularisation simply, the restoration of adequate blood and oxygen supplies to the heart is the collective term for the response to the symptoms of coronary artery disease (CAD), including heart attacks and angina. The new guidelines will be presented at the ESC Congress in Stockholm on 29 August during the Clinical Practice Guidelines session in lecture room Stockholm, Zone K, starting at 0845hrs.

These guidelines reflect the fact that there are many options available to physicians to treat the many forms of CAD, both acute and non-acute. These include surgery, stent implantation and drug therapies, and the options cross traditional boundaries of medicine such as cardiology and surgery. “Our intention in writing these guidelines was to give patient-centred recommendations that lead to the most appropriate treatment regime for the different types of CAD,” said Doctor William Wijns of the ESC and Co-Chair of the Task Force. “We also wanted to provide reference materials based on best practice but not conditioned by the skill and preferences of individual physicians. The major challenge faced by physicians is not how to treat the CAD patient, but which of the many treatment options to select.”

The Task Force was made up of 24 experts, drawn equally from surgeons, interventional cardiologists and general cardiologists, and representing the ESC and the EACTS. The new guidelines are noteworthy for three main reasons:

– They are an example of strong co-operation between the ESC and the EACTS, and have proved to very successful in meeting the objectives.

– The content addresses the full extent of CAD, and of associated diseases, which was previously covered in separate guidelines, or not at all.

– The guidelines introduce the concept of Heart Teams, essentially a grouping from across disciplines ensuring when practical that the patient is fully informed and takes part in the key decisions. The heart team should include one of each of the following specialists; interventional cardiologist, clinical cardiologist, and cardiac surgeon.

The guidelines encompass the full extent of CAD treatment and expected outcomes, including managing stable and unstable angina, myocardial infarction, diabetes-related symptoms and associated renal failure. Recommendations are made on all treatment options, from the technical aspects of stent implantation to the use of imaging technologies, and from risk management to follow-up activities.

The establishment of Heart Teams is a vital recommendation for medical teams everywhere, and formalises the make-up of the multi-discipline team responsible for patient care following CAD treatment. Co-Chair, Professor Philippe Kolh of the EACTS explains, “It is important that physicians offer patients the opportunity to influence the response to their condition. Clearly, for acute cases, such flexibility can be difficult to accommodate, but for the 30 percent of patients with stable conditions, it is an important factor. Immediate but less durable treatments such as a stent implantation may not be the right choice for some patients. Depending on their lifestyle and responsibilities, some may prefer to elect for a surgical procedure that offers a longer-term result.”

Practitioners that will be using the new guidelines, as well as journalists, are offered the opportunity to have an open discussion and Q&A with Doctor Wijns and Professor Kolh and members of the Task Force. A ‘Meet the Guidelines Task Force’ session takes place on Tuesday 31 August in lecture room Moscow, Zone A starting at 1005hrs.

Sources: European Society of Cardiology (ESC), AlphaGalileo Foundation.

Masimo (Nasdaq: MASI) announced that a new randomized controlled trial published in Anesthesia & Analgesia shows that clinicians using Masimo Pleth Variability Index (PVI®) significantly improved fluid management and reduced lactate levels in patients during and after surgery, compared to patients managed by standard care without PVI(1). Multiple previous studies(2,3,4) have shown that PVI predicts fluid responsiveness, defined as a significant increase in cardiac output after fluid administration, but this is the first published study to show that the use of PVI can improve patient management compared to a group of patients not managed with PVI.

Although fluid administration is critical to optimizing patient status and enabling end organ preservation, unnecessary fluid administration is associated with increased morbidity and mortality. Traditional invasive measurements such as central venous pressure (CVP) are not reliable in predicting whether a patient will benefit from fluid administration, and newer methods of predicting fluid responsiveness are invasive and/or costly. Masimo PVI provides clinicians with a noninvasive, continuous, and cost-effective measure in assessing whether patients will benefit from fluid administration to enable more personalized and targeted fluid therapy.

In the current study, researchers from the University Catholique de Louvain, St. Luc Hospital in Brussels, Belgium, randomized 82 patients undergoing abdominal surgery into two groups, a control group where fluid management was guided by standard care through CVP and clinician assessment, and the PVI group where fluid management was guided by standard care and PVI values from a Masimo Radical-7® Pulse CO-Oximeter®. In the PVI group, 500mL of crystalloids were infused at induction, followed by 2mL per kg per hour continuous infusion. A 250mL bolus of colloid was added if the PVI exceeded 13% for more than 5 minutes. In the control group, 500mL of crystalloids were infused at induction, followed by continuous infusion of crystalloids (4 to 8mL per kg per hour) and a 250mL bolus of colloids was given to compensate acute blood losses (>50mL), maintain mean arterial pressure above 65mmHg and the central venous pressure above 6mmHg.

The results showed that the PVI group received significantly lower amounts of intraoperative crystalloids (P=0.004) and total volume infused (P=0.049), and lactate levels were significantly lower during surgery (1.2 mmol/L +/- 0.6 vs 1.6 +/- 1.2, P=0.04), 24-hours post-operatively (1.4 +/- 0.3 vs 1.8 +/- 1.0, P=0.02), and 48-hour post-operatively (1.2 +/- 0.3 vs 1.4 +/- 0.4, P=0.03). The researchers concluded that “PVI-based goal directed fluid management reduced the volume of intraoperative fluid infused and reduced both intraoperative and postoperative lactate levels.” Study authors also noted that the reduction in lactate levels for PVI-guided patients suggests that “PVI-guided fluid management may lead to fluid administration that is tailored to each individual patient’s needs.”

PVI is available as part of Masimo rainbow® SET platform the first-and-only technology to noninvasively and continuously measure total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVI®), perfusion index (PI), and acoustic respiration rate (RRa™), in addition to the ‘gold standard’ Measure-Through Motion and Low Perfusion performance of Masimo SET® oxyhemoglobin (SpO2), and pulse rate (PR).

“The clinical merit of using a dynamic index like PVI to guide fluid administration relates to a timing issue,” stated William E. Johnston, MD, Professor and Associate Chair, Vice Chair of Academic Affairs in the Department of Anesthesiology at Scott & White Memorial Hospital in Temple, Texas. “What’s so unique about PVI is that it allows the medical team to rapidly fine tune fluid administration using a Masimo Radical-7 Pulse CO-Oximeter in the operating room before global hypovolemia and hypoperfusion occur. Consequently, an appropriate amount of fluid can be administered at the most opportune time.”

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care… by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, and SEDLine are trademarks or registered trademarks of Masimo Corporation.

References

(1) Forget, Patrice; Lois, Fernande; De Kock, Marc. “Goal-Directed Fluid Management Based on the Pulse Oximeter-Derived Pleth Variability Index Reduces Lactate Levels and Improves Fluid Management.” Anesthesia & Analgesia. August 2010. Published online ahead of print here.

(2) Cannesson M, Desebbe O, Rosamel P, Delannoy B, Robin J, Bastien O, Lehot JJ. “Pleth variability Index to Monitor the Respiratory Variations in the Pulse Oximeter Plethysmographic Waveform Amplitude and Predict Fluid Responsiveness in the Operating Theatre.” British Journal of Anaesthesia August 2008; 101(2):200-6. Available online here.

(3) Markus Zimmerman, Thomas Feibicke, Cornelius Keyl, Christopher Prasser, Stefan Moritz, Bernhard M. Graf, and Christoph Wiesenack. “Accuracy of Stroke Volume Variation Compared with Pleth Variability Index to Predict Fluid Responsiveness in Mechanically-ventilated Patients Undergoing Major Surgery.” European Journal of Anaesthesiology June 2010; 27(6):555-61.

(4) M. Feissel, R. Kalakhy, J. Badie, G. Robles, J. Faller, JL. Teboul. “Plethysmography Variability Index: A New Fluid Responsiveness Parameter.” Presented at the 29th International Symposium on Intensive Care and Emergency Medicine (ISICEM) Annual Meeting, March 25, 2009, Brussels, Belgium.

Source: Masimo Corporation